Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment.
Yusuke AndoMasatoshi IshigamiYoji IshizuTeiji KuzuyaTakashi HondaKazuhiko HayashiTetsuya IshikawaIsao NakanoYoshiki HirookaHidemi GotoPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2017)
Our findings indicate the importance of continuous HCC surveillance especially in patients with advanced age, cirrhosis, and/or higher serum levels of HBcrAg, even if they achieve HBV-DNA disappearance.